Patient preference, efficacy, and compliance with zoledronic acid for glucocorticoid-induced osteoporosis in patients with autoimmune diseases.

导出 LinkOut

翻译打印收藏纠错

作者： Ji-Won,Kim ^[1] ; Ju-Yang,Jung ^[1] ; Hyoun-Ah,Kim ^[1] ; Heejun,Son ^[1] ; Chang-Hee,Suh ^[1]

作者单位： Department of Rheumatology, Ajou University School of Medicine, Suwon 16499, Republic of Korea. ^[1] Department of Molecular Science and Technology, Ajou University, Suwon 16499, Republic of Korea. ^[2]

关键词 autoimmune diseases glucocorticoid-induced osteoporosis patient preference treatment efficacy zoledronic acid

主题词人类(Humans);骨质疏松(Osteoporosis);女(雌)性(Female);糖皮质激素类(Glucocorticoids);男(雄)性(Male);骨密度保护剂(Bone Density Conservation Agents);自身免疫疾病(Autoimmune Diseases);中年人(Middle Aged);病人意愿(Patient Preference);骨密度(Bone Density);老年人(Aged);投药, 口服(Administration, Oral);二膦酸盐类(Diphosphonates);病人满意度(Patient Satisfaction);治疗结果(Treatment Outcome);咪唑类(Imidazoles)

DOI 10.1093/postmj/qgae003

PMID 38297995

发布时间 2024-04-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Postgraduate medical journal

2024年100卷1183期

334-341页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Patient preference, efficacy, and compliance with zoledronic acid for glucocorticoid-induced osteoporosis in patients with autoimmune diseases.

Postgraduate medical journal

相似文献

Postgraduate medical journal

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Patient preference, efficacy, and compliance with zoledronic acid for glucocorticoid-induced osteoporosis in patients with autoimmune diseases.

Postgraduate medical journal

相似文献

Postgraduate medical journal

相关期刊

检索历史清除